Literature DB >> 7011533

Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth.

I R Hart, J E Talmadge, I J Fidler.   

Abstract

The metastatic properties of the M5076 tumor, a reticulum cell sarcoma of ovarian origin, were examined. This tumor metastasizes preferentially to the peritoneal viscera (liver, ovaries, spleen, and kidneys) regardless of the site or route of tumor cell injection. Subcutaneous tumor growth followed by direct invasion into the peritoneum resulted in extensive generalized peritoneal involvement. However, when tumor cells were injected in the dorsum, external ear, or footpad, fewer and primarily hepatic metastases developed. Hepatic, splenic, ovarian, and renal tumor colonies were formed after i.v. injection of tumor cells. Radiolabeled tumor cells were used to study the arrest, distribution, and survival of tumor cells injected i.v. These tumor cells were rapidly arrested in the lungs and were retained there for 3 to 4 days. They then slowly detached, recirculated, and were arrested in the liver, where they subsequently developed into tumor nodules. These results strongly support the "soil-seed" hypothesis of metastatic growth and demonstrate that long-term retention of tumor cells in an organ need not result in the formation of a clinically obvious tumor nodule.

Entities:  

Mesh:

Year:  1981        PMID: 7011533

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

1.  Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in mice.

Authors:  N C Phillips; M S Tsao
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Liposomal formulation and antitumor activity of 14-O-palmitoyl-hydroxyrubicin.

Authors:  R Perez-Soler; W Priebe
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Organ distribution of experimental metastases of a human colorectal carcinoma injected in nude mice.

Authors:  J E Price; L M Daniels; D E Campbell; R Giavazzi
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

4.  The growth and metastasis of four commonly used tumour lines implanted into eight different sites: evidence for site and tumour effects.

Authors:  W S Chan; C M Page; J R Maclellan; G A Turner
Journal:  Clin Exp Metastasis       Date:  1988 May-Jun       Impact factor: 5.150

5.  Development of lymphosarcoma lines with high metastatic ability to lymph nodes and visceral organs in BALB/c mice.

Authors:  T Tsuruo; T Oh-Hara; T Yamori; S Tsukagoshi; T Ishikawa; H Sugano
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

Review 6.  Angiogenesis, metastasis, and endogenous inhibition.

Authors:  M Kirsch; G Schackert; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

7.  Biological heterogeneity and radiation sensitivity of in vitro propagated lung metastatic lines originated from a transplantable squamous cell carcinoma of BALB/c mouse.

Authors:  R J Jamasbi; E H Perkins
Journal:  In Vitro Cell Dev Biol       Date:  1990-03

Review 8.  Biology of human colon cancer metastasis.

Authors:  M Gutman; I J Fidler
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

9.  The selective nature of metastasis.

Authors:  J E Talmadge
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

10.  Ewing's sarcoma: overcoming the therapeutic plateau.

Authors:  Vivek Subbiah; Razelle Kurzrock
Journal:  Discov Med       Date:  2012-06       Impact factor: 2.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.